United Kingdom Healthcare Equipment & Supplies

Tissue Regenix Group PLC (TRX)

Track

Track

Ticker: TRX Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tissue Regenix Group PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Brian Phillips Non-Executive Director Executive Director
Transaction date
Purchase
Price
370.25
Quantity 80,113
Value £3,543,271
David Cocke Chief Financial Officer Officer
Transaction date
Purchase
Price
219.25
Quantity 9,570
Value £3,348,963
2.9
Daniel Lee Chief Executive Officer Officer
Transaction date
Purchase
Price
269.74
Quantity 8,460
Value £4,202,034
2.9
Daniel Lee Chief Executive Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 2,000,000
Value US$10,409
Trevor Phillips Non-executive director Executive Director
Transaction date
Purchase
Price
0.01
Quantity 2,758,000
Value £14,990
David Cocke Chief Financial Officer Officer
Transaction date
Purchase
Price
0.00
Quantity 1,785,000
Value £7,854
2.9
Daniel Lee Chief Executive Officer Officer
Transaction date
Purchase
Price
0.00
Quantity 1,785,000
Value £7,854
D R Lee Chief Executive Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 1,408,450
Value £7,535
G B Phillips Non-executive director Executive Director
Transaction date
Purchase
Price
0.01
Quantity 9,000,000
Value £54,729
David Cocke Chief Financial Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 1,086,000
Value £7,276
G B Phillips Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.01
Quantity 2,886,671
Value £17,320
G B Phillips Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.01
Quantity 3,463,085
Value £20,617
2.9
Daniel Lee Chief Executive Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 2,068,750
Value £14,274
David Cocke Chief Financial Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 2,821,000
Value £18,054
Trevor Phillips Independent Non-Executive Director Non-Executive Director
Transaction date
Purchase
Price
0.01
Quantity 2,777,770
Value £15,000
Gareth Hywel Jones Interim CEO Officer
Transaction date
Purchase
Price
0.00
Quantity 24,000,000
Value £60,000
Alan Jonathan Richard Miller NED
Transaction date
Purchase
Price
0.00
Quantity 94,000,000
Value £235,000
Randeep Singh Grewal NED
Transaction date
Purchase
Price
0.00
Quantity 90,000,000
Value £225,000
Jonathan Martin Glenn Interim Chair Director
Transaction date
Purchase
Price
0.00
Quantity 40,000,000
Value £100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-15 2023-09-15 B Purchase
2.3
Brian Phillips

Non-Executive Director

Executive Director
80,113
370.25
£3,543,271 		80,113 370.25 £3,543,271
2023-04-05 2023-04-04 B Purchase David Cocke

Chief Financial Officer

Officer
9,570
219.25
£3,348,963 		9,570 219.25 £3,348,963
2023-04-05 2023-04-04 B Purchase
2.9
Daniel Lee

Chief Executive Officer

Officer
8,460
269.74
£4,202,034 		8,460 269.74 £4,202,034
2022-09-29 2022-09-28 B Purchase
2.9
Daniel Lee

Chief Executive Officer

Officer
2,000,000
0.01
US$10,409 		2,000,000 0.01 US$10,409
2022-04-20 2022-04-19 B Purchase Trevor Phillips

Non-executive director

Executive Director
2,758,000
0.01
£14,990 		2,758,000 0.01 £14,990
2022-04-06 2022-04-05 B Purchase David Cocke

Chief Financial Officer

Officer
1,785,000
0.00
£7,854 		1,785,000 0.00 £7,854
2022-04-06 2022-04-05 B Purchase
2.9
Daniel Lee

Chief Executive Officer

Officer
1,785,000
0.00
£7,854 		1,785,000 0.00 £7,854
2021-12-23 2021-12-22 B Purchase D R Lee

Chief Executive Officer

Officer
1,408,450
0.01
£7,535 		1,408,450 0.01 £7,535
2021-09-24 2021-09-23 B Purchase G B Phillips

Non-executive director

Executive Director
9,000,000
0.01
£54,729 		9,000,000 0.01 £54,729
2021-09-09 2021-09-09 B Purchase David Cocke

Chief Financial Officer

Officer
1,086,000
0.01
£7,276 		1,086,000 0.01 £7,276
2021-06-29 2021-06-25 B Purchase G B Phillips

Non-Executive Director

Executive Director
2,886,671
0.01
£17,320 		2,886,671 0.01 £17,320
2021-06-23 2021-06-18 B Purchase G B Phillips

Non-Executive Director

Executive Director
3,463,085
0.01
£20,617 		3,463,085 0.01 £20,617
2021-05-11 2021-05-10 B Purchase
2.9
Daniel Lee

Chief Executive Officer

Officer
2,068,750
0.01
£14,274 		2,068,750 0.01 £14,274
2021-05-10 2021-05-07 B Purchase David Cocke

Chief Financial Officer

Officer
2,821,000
0.01
£18,054 		2,821,000 0.01 £18,054
2021-01-06 2021-01-06 B Purchase Trevor Phillips

Independent Non-Executive Director

Non-Executive Director
2,777,770
0.01
£15,000 		2,777,770 0.01 £15,000
2020-06-05 2020-06-05 B Purchase Gareth Hywel Jones

Interim CEO

Officer
24,000,000
0.00
£60,000 		24,000,000 0.00 £60,000
2020-06-05 2020-06-05 B Purchase Alan Jonathan Richard Miller

NED
94,000,000
0.00
£235,000 		94,000,000 0.00 £235,000
2020-06-05 2020-06-05 B Purchase
Randeep Singh Grewal

NED
90,000,000
0.00
£225,000 		90,000,000 0.00 £225,000
2020-06-05 2020-06-05 B Purchase
Jonathan Martin Glenn

Interim Chair

Director
40,000,000
0.00
£100,000 		40,000,000 0.00 £100,000
Explore more

More insider trading research around Tissue Regenix Group PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe